Codes / ICD10CM / H16.402

H16.402 Unspecified corneal neovascularization, left eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Unspecified corneal neovascularization, left eye

Summary

Unspecified corneal neovascularization, left eye, refers to the abnormal growth of blood vessels onto the cornea of the left eye without further specification of the underlying cause. This condition can impair vision and may result from various factors, including inflammation, injury, or ocular diseases. Evaluation is necessary to determine the cause and appropriate management.

Causes

Corneal neovascularization can be triggered by inflammation, infection, or injury to the cornea. Common causes include chronic dry eye, contact lens wear, ocular surgery, or conditions like uveitis. It may also develop secondary to corneal edema, chemical burns, or autoimmune disorders affecting the eye.

Risk Factors

  • Prolonged contact lens use, especially with poor hygiene.
  • History of eye trauma or surgery.
  • Chronic ocular inflammation or infection.
  • Underlying systemic conditions like diabetes or autoimmune diseases.
  • Use of topical medications that disrupt corneal health.

Symptoms

  • Blurred or reduced vision in the left eye.
  • Eye redness or irritation.
  • Sensitivity to light (photophobia).
  • A feeling of a foreign object in the eye.
  • Visible blood vessels on the cornea (may be observed during exam).

Diagnosis

Diagnosis involves a comprehensive eye exam, including slit-lamp microscopy to assess the extent of vascular growth. Additional tests, such as corneal topography or fluorescein angiography, may be used to evaluate the severity and underlying causes. A thorough history of ocular health and systemic conditions is also essential.

Treatment Options

Treatment focuses on addressing the underlying cause and reducing vascular growth. Options may include topical anti-vascular endothelial growth factor (anti-VEGF) agents, corticosteroids to control inflammation, or lubricating eye drops for dry eye. In severe cases, surgical interventions like phototherapeutic keratectomy or corneal transplantation may be considered.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and the extent of vascularization. Early intervention can improve outcomes, but persistent neovascularization may lead to vision impairment. Regular follow-up with an ophthalmologist is necessary to monitor progression and adjust treatment as needed.

Complications

Complications may include reduced visual acuity, corneal scarring, or increased risk of infection. Severe cases can lead to corneal opacity or perforation, requiring more aggressive management.

Lifestyle & Prevention

  • Maintain good eye hygiene, especially with contact lens use.
  • Protect the eyes from injury or chemical exposure.
  • Manage underlying conditions like diabetes or autoimmune diseases.
  • Use lubricating eye drops to prevent dry eye.
  • Avoid smoking, which can exacerbate ocular inflammation.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, severe eye pain, increased redness, or discharge. Regular check-ups are recommended if you have a history of eye disease or risk factors for corneal neovascularization.

Tips for Medical Coders

Use H16.402 for unspecified corneal neovascularization affecting the left eye. Ensure documentation specifies the eye involved and confirms the absence of further details about the underlying cause. Verify that the diagnosis aligns with clinical findings and that no more specific code (e.g., for a known etiology) is applicable.

Book a walkthrough

H16.402 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.